EFFECT OF DISTRACTION METHODS ON PAIN AND ANXIETY DURING INTRAMUSCULAR INJECTION IN CHILDREN
THE EFFECT OF DISTRACTION METHODS ON PAIN AND ANXIETY DURING INTRAMUSCULAR INJECTION IN CHILDREN AGED 6-12 YEARS
1 other identifier
interventional
180
1 country
1
Brief Summary
This thesis study was conducted in an unblinded, randomized controlled experimental manner in order to analyze the effect of attention-drawing methods that can be used during intramuscular injection in children on pain and anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2021
CompletedFirst Submitted
Initial submission to the registry
August 12, 2023
CompletedFirst Posted
Study publicly available on registry
August 25, 2023
CompletedAugust 25, 2023
August 1, 2023
Same day
August 12, 2023
August 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Pain was measured by Wong- Baker Faces Pain Scale
The scale, which was developed by Wong and Baker in 1981 and renewed in 1983, is one of the most common methods used in pain assessment. The use of the scale is suitable for 3 years old and above. Before using the scale, the pain level of the statements on the scale should be explained to the child.
at 1st minute before the procedure
Pain was measured by Wong- Baker Faces Pain Scale
The scale, which was developed by Wong and Baker in 1981 and renewed in 1983, is one of the most common methods used in pain assessment. The use of the scale is suitable for 3 years old and above. Before using the scale, the pain level of the statements on the scale should be explained to the child.
during the procedure
Pain was measured by Wong- Baker Faces Pain Scale
The scale, which was developed by Wong and Baker in 1981 and renewed in 1983, is one of the most common methods used in pain assessment. The use of the scale is suitable for 3 years old and above. Before using the scale, the pain level of the statements on the scale should be explained to the child.
at 1st minute after the procedure
Fear was measured by Child Fear Scale
In this scale, in which neutral anxiety expression is indicated as (0) and high level of anxiety/fear is indicated as (4), there are facial expressions that progress gradually from neutral anxiety expression to high level of anxiety.
at 1st minute before the procedure
Fear was measured by Child Fear Scale
In this scale, in which neutral anxiety expression is indicated as (0) and high level of anxiety/fear is indicated as (4), there are facial expressions that progress gradually from neutral anxiety expression to high level of anxiety.
during the procedure
Fear was measured by Child Fear Scale
In this scale, in which neutral anxiety expression is indicated as (0) and high level of anxiety/fear is indicated as (4), there are facial expressions that progress gradually from neutral anxiety expression to high level of anxiety.
at 1st minute after the procedure
Study Arms (3)
distraction method
EXPERIMENTALvideo game playing
distraction
EXPERIMENTALkaleidoscope
distraction methods
EXPERIMENTALvirtual reality glasses
Interventions
This thesis study was conducted with randomized controlled methods for control in order to analyze the effect of drawing attention to different directions during intramuscular use in countries to what extent the methods of drawing attention to pain and anxiety.
Eligibility Criteria
You may qualify if:
- Children between the ages of 6-12 and their families who speak Turkish and accepted the voluntary informed consent form verbally and in writing.
- Children who do not have a chronic disease (Children with chronic diseases such as DM, asthma, hypertension, meningitis, epilepsy, etc. will not be included in the study as their response levels to pain will vary.)
- Children who have not taken an analgesic drug in the last 6 hours
- No physical or mental illness
- Children who have no suspicion of covid 19 transmission in their family or themselves
- Children whose vital signs are in parameters suitable for their age will be taken.
You may not qualify if:
- Children who did not accept the voluntary informed consent form verbally and in writing
- Children with chronic diseases (Children with chronic diseases such as DM, asthma, hypertension, meningitis, epilepsy, etc. will not be included in the study as their response levels to pain will vary.)
- Children who have taken an analgesic drug in the past 6 hours
- Those who have a suspected covid 19 transmission in their family or themselves
- Children with any physical or mental illness will not be included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Senem Merve KURT
Mersin, Merkez, 33010, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 12, 2023
First Posted
August 25, 2023
Study Start
October 15, 2021
Primary Completion
October 15, 2021
Study Completion
December 15, 2021
Last Updated
August 25, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share